baber/WOPTO huggingface dataset:
Patent AU-784408-B2 (AU)
Title: Pressure measurement device comprising a motorized load sensor and a process for controlling the device
Inventor: CHEVALLET JACQUES
IPC: G01L7/00
Filed: 2002-01-23
Granted: 2006-03-30
Abstract: The invention proposes a device for measuring the pressure of blood, intended to engage with a section (16) for measuring the pressure of blood, which section comprises a membrane (38) which is axially deformable under the effect of the blood pressure and which is designed to be mounted on a support structure (20, 22) bearing especially a load sensor (26) arranged substantially facing the membrane (38), characterized in that it comprises controlled means (58) for the relative axial displacement of the sensitive member (52) of the load sensor (26), with respect to the support structure (20, 22), so that the axial position of the sensitive member (52) can be adjusted with respect to the external face (42) of the membrane (38), especially for the purpose of carrying out an initial calibration operation. The invention also proposes a process for controlling the device. <IMAGE>
Patent AU-607981-B2 (AU)
Title: Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocularpressure
Inventor: BITO LASZLO Z
IPC: A61K31/557
Filed: 1988-03-30
Granted: 1991-03-21
Abstract: This invention provides a method for treating ocular hypertension or glaucoma in a subject's eye. The method comprises contacting the surface of the eye with an effective intraocular pressure reducing amount of a mixture of an adrenergic blocking agent and a prostaglandin or prostaglandin derivative in an ophthalmically compatible carrier, so as to reduce the intraocular pressure of the eye and maintain such reduced intraocular pressure. This invention also provides a composition for topical treatment of ocular hypertension or glaucoma in the eye of a subject. The composition comprises an effective intraocular pressure reducing amount of a mixture of an adrenergic blocking agent and a prostaglandin or prostaglandin derivative in an ophthalmically compatible carrier.
Patent AU-647614-B2 (AU)
Title: Knife blades
Inventor: WILLIAMS DAVID MARK
IPC: C21D9/18
Filed: 1992-04-24
Granted: 1994-03-24
Abstract: PCT No. PCT/GB92/00756 Sec. 371 Date Dec. 8, 1993 Sec. 102(e) Date Dec. 8, 1993 PCT Filed Apr. 24, 1992 PCT Pub. No. WO92/19424 PCT Pub. Date Nov. 12, 1992.The invention relates to knife blades and in particular to a method of their production, and has for its object the provision of a knife blade with a cutting edge formed by a surface harder than the material of the body of the blade. This objective is met by a method comprising grinding a first face (2) of a V-shaped cutting edge to one side of the blank (1) to locate the lower edge of the first side face (2) at the approximate mid-point across the thickness of the blank (1), providing on the partly-ground blank (1) a hard surface (3) around the periphery of the blank (1) at least over the height of the first ground face (2) and grinding a second face (4) of the V-shaped cutting edge to the opposite side of the blank (1), to locate the V-shaped cutting edge at the approximate mid-point across the thickness of the blank (1).
Patent AU-555325-B2 (AU)
Title: Fibre optic amplifier
Inventor: JOHN SHAW HERBERT
IPC: H01S3/06
Filed: 1983-07-26
Granted: 1986-09-18
Abstract: An optical fiber bidirectional amplifier includes a pair of small diameter optical fibers (12a, 12b), arranged in a side- by-side configuration, the first fiber (12a) providing a pumping source and the second fiber (12b) doped with a material which will lase at the frequency of the signal to be amplified. The signal to be amplified propagates through the second fiber (12b) to stimulate emission of coherent light from the lasing material, resulting in amplification of the signal. The refractive index of the first and second fibers (12a, 12b) is substantially identical, but the coupling characteristic provided by the geometrical relationship between the pair of fibers (12a, 12b) yields a wavelength dependent coupling efficiency. Specifically, the coupling efficiency at the wave- lenght of the pumping source is relatively high, while the coupling efficiency at the wavelength of the signal to be amplified is relatively low. Thus, the pumping illumination is coupled from the first fiber (12a) to the second fiber (12b) to stimulate the doping material in the second fiber (12b), while the signal to be amplified remains relatively uncoupled, and is amplified by the coherent light emitted by the lasing material.
Patent AU-607532-B2 (AU)
Title: Process for microencapsulation, uses of polymers prepared by said process, and compositions containing polymers prepared by said process
Inventor: KIELBANIA ANDREW JOHN JR
IPC: B01J13/02
Filed: 1988-08-22
Granted: 1991-03-07
Abstract: A process for encapsulating a wide variety of target materials, including both hydrophilic and hydrophobic materials, employs condensation of two reactive compounds to form shells around core phase drops/particles including target mateial dispersed in a continuous phase. One of the reactive compounds has at least two active methylene functional groups per molecule, the other being an active methylene-reactive crosslinking agent. Either type of the reactive compounds can be dispersed in the continuous phase, the other being dispersible in the core phase. Applications include controlled release mocroencapsulation of agriculture chemicals and biocides.
Patent AU-562113-B2 (AU)
Title: Benzoxazolinones
Inventor: CAIGNARD DANIEL HENRI
IPC: C07D263/58
Filed: 1983-11-23
Granted: 1987-05-28
Abstract: The invention relates to compounds of the formula:   <IMAGE>   in which R represents hydrogen or a lower alkyl radical and R1 and R2 separately represent hydrogen, a lower alkyl, cycloalkyl or benzyl radical, or represent, together with the nitrogen atom to which they are bonded, a heterocyclic radical such as a morpholino, 4-(pyrimidin-2-yl)-piperazinyl or 4-phenylpiperazinyl the phenyl radical of which being optionally substituted by halogen, lower alkoxy or trifluoromethyl, having CNS activity and particularly hypnotic properties. Moreover the compounds in which R1 and R2 are hydrogen can be used in the treatment of heart failure.
Patent AU-603710-B2 (AU)
Title: Data storage apparatus
Inventor: CRONIN DAVID V
IPC: G11B21/08
Filed: 1988-10-14
Granted: 1990-11-22
Abstract: A magnetic data storage system for use with a double sided disk in which a prerecorded pattern of opaque optical lines is used to define the tracks in which magnetic data is to be stored. A separate optical system including an illumination source and a photosensitive detector is provided on a read/write assembly for each side of the disk. Each detector is designed also to serve as a reference grating. The illumination source is designed to image the prerecorded pattern of optical lines on the reference grating as an indication of the alignment of the read/write head of the assembly and a desired data track and any misalignment of the head and track generates a servo signal. The detector uses four separate photocells interleaved in a prescribed fashion to form a quadrature detector that is adjustable to compensate for various non-uniformities. One form of illumination source uses a surface-emitting light emitting diode and optics for forming a multiple beam source.
Patent AU-618975-B2 (AU)
Title: Method of making metal matrix composite with the use of a barrier
Inventor: AGHAJANIAN MICHAEL KEVORK
IPC: C04B35/65
Filed: 1988-12-01
Granted: 1992-01-16
Abstract: A net shaped ceramic-reinforced aluminum matrix composite is formed by forming a permeable mass of ceramic material (10) with a defined surface boundary having a barrier, and contacting a molten aluminum-magnesium alloy (20) with the permeable mass of ceramic material (10) in the presence of a gas comprising from about 10 to 100 % nitrogen, by volume, balance nonoxidizing gas, e.g. hydrogen or argon. Under these conditions, the molten alloy (20) spontaneously infiltrates the ceramic mass under normal atmospheric pressures until it reaches the barrier. A solid body of the alloy (20) can be placed adjacent to a permeable bedding of ceramic material (10) having a barrier, and brought to the molten state, preferably to at least about 700 DEG C, in order to form the net shape aluminum matrix composite by infiltration. In addition to magnesium, auxiliary alloying elements may be employed with aluminum. The resulting composite products may contain a discontinuous aluminum nitride phase in the aluminum matrix.
Patent AU-727941-B2 (AU)
Title: Frequency tracking for communication signals using M-ary orthogonal Walsh modulation
Inventor: AGRAWAL AVNEESH
IPC: H03L7/06
Filed: 1997-03-26
Granted: 2001-01-04
Abstract: A frequency tracking loop for a communication system using orthogonal Walsh modulation is provided. The frequency tracking loop includes a correlator (120), such as a fast Hadamard transformation device, and a discriminator (130). The correlator (120) produces a correlation vector (122) representing the result of correlating the input signal with each of a set of Walsh functions, with corresponding index values. The discriminator (130) produces a frequency error signal (ê) based on the correlator (120) output with the highest energy level and other correlator outputs whose indices are related to the index of highest energy correlator output by powers of two. The frequency error signal (ê) is generated by producing a cross product between the highest energy output and one or more of the other related correlator outputs. In further aspects, a filter (140) can be used to further shape the resulting error signal (ê) and form a frequency offset estimate signal ({circumflex over (f)}).
Patent AU-572132-B2 (AU)
Title: Metallisation of electrically insulating flexible plastic films
Inventor: CASSAT ROBERT
IPC: C25D5/56
Filed: 1984-04-13
Granted: 1988-05-05
Abstract: Electrically insulating polyimide/aromatic polyamide film substrates are conductively metallized, e.g., to provide highly thermally stable base members useful in the fabrication of printed circuits and the like, by (1) shaping into such essentially thermosetting film substrate an intimate homogeneous admixture of a film-forming polyimide/aromatic polyamide matrix having from 20 to 60 percent by total weight of said admixture of finely divided, non-conductive metal oxide particles uniformly distributed therein, (2) disrupting at least one face surface of said shaped film substrate to expose thereon a plurality of said finely divided, non-conductive metal oxide particles, (3) treating said at least one disrupted face surface with a preferably borohydride reducing agent to reduce said exposed metal oxide particles into a layer of electrically conductive free metal, whereby said at least one surface is rendered electrically conductive, and, advantageously, (4) electrolytically depositing a reinforcing, electrically conductive metallic overlayer atop said first layer of electrically conductive free metal.
Patent AU-769772-B2 (AU)
Title: Continuous process for preparing a polyurethane latex
Inventor: SKAGGS KENNETH W
IPC: C08G18/28
Filed: 2000-02-07
Granted: 2004-02-05
Abstract: A polyurethane/urea/thiourea latex having a narrow molecular weight polydispersity and sub-micron particle size can be prepared by first preparing a high solids (between about 65% and 74% solids) latex of a polyurethane/urea/thiourea prepolymer, then contacting the emulsion with a chain-extending reagent under such conditions to form the polymer latex.
Patent AU-701313-B2 (AU)
Title: A method for testing the authenticity of a data carrier
Inventor: LAMLA MICHAEL
IPC: G06K19/10
Filed: 1995-06-02
Granted: 1999-01-28
Abstract: PCT No. PCT/EP95/02104 Sec. 371 Date Jul. 15, 1996 Sec. 102(e) Date Jul. 15, 1996 PCT Filed Jun. 2, 1995 PCT Pub. No. WO95/34054 PCT Pub. Date Dec. 14, 1995A method for testing the authenticity of a data carrier having at least an integrated circuit with memory units and logic units as well as a data line for data exchange with an external device. The invention is characterized in that the integrated circuit additionally has a separate hard-wired circuit for transmitting and/or receiving data during the power-up sequence, which is used for authenticity testing, the first transmission or reception of data being completed within a defined time domain of the power-up sequence in which the data line has no defined state.
Patent AU-568650-B2 (AU)
Title: Packaging machine
Inventor: JURCZENIA EDWARD
IPC: B65B9/20
Filed: 1984-05-24
Granted: 1988-01-07
Abstract: @ A machine for forming, continuously, distinct portions of smokeless tobacco in a pouch or pocket form, and continuously forming a chain of individual pouches containing the distinct portions of smokeless tobacco, cutting each pouch from a string of pouches, counting out a pre-set number of pouches for filling a container with the pre-set number of pouches with a set moisture content; further indexing each container relative to its production cycle, including means for rejecting improperly filled containers based on improperly filled individual or a plurality of pouches, closing each container with a lid, and pneumatic and other control means for controlling the production cycle of the machine.
Patent AU-715748-B2 (AU)
Title: Taxane derivatives, the preparation thereof and formulations containing them
Inventor: BOMBARDELLI EZIO
IPC: A61P35/00
Filed: 1997-04-29
Granted: 2000-02-10
Abstract: PCT No. PCT/EP97/02198 Sec. 371 Date Oct. 6, 1998 Sec. 102(e) Date Oct. 6, 1998 PCT Filed Apr. 29, 1997 PCT Pub. No. WO97/43291 PCT Pub. Date Nov. 20, 1997The present invention relates to the preparation of taxane derivatives starting from 10-deacetyl-baccatine III, 14-hydroxy-10-deacetyl-baccatine 111, 19-hydroxy-10-deacetyl-baccatine III and their esters at C13, reacting the respective 10-dehydro derivatives with hydrazine, hydroxylamine and derivatives thereof. The novel compounds contain a pyrazoline group involving the C7 and C9 carbons. The C13 esters of these molecules with substituted isoserine chains exert antitumor activity inhibiting cell proliferation of normal and resistant tumor cell lines and inducing apoptosis. These molecules due to their basic character can be administered upon salification in an aqueous medium without requiring the use of toxic surfactants.
Patent AU-732707-B2 (AU)
Title: Human thymosin beta15 gene, protein and uses thereof
Inventor: ZETTER BRUCE R
IPC: C12N15/09
Filed: 1997-06-13
Granted: 2001-04-26
Abstract: The present inventors have now discovered that humans have a gene that encodes a novel protein of the thymosin  beta  family. This novel protein, herein referred to as thymosin  beta 15, has the ability to bind and sequester G-actin, like other members of the thymosin  beta  family, but unlike what is known about other members it also directly regulates cell motility in prostatic carcinoma cells. The present invention is direct to an isolated cDNA encoding the human thymosin  beta 15 gene (SEQ ID NO: 1) and have deduced the amino acid sequence (SEQ ID NO: 2).
Patent AU-571599-B2 (AU)
Title: Processing food in particulate form
Inventor: MACKENZIE ROSS ALAN
IPC: A23L7/109
Filed: 1984-10-29
Granted: 1988-04-21
Abstract: A method and apparatus for processing a foodstuff raw material in particulate form involve preheating the particulate matter in a preheating chamber (6) and then subjecting the preheated matter to heating by microwave energy in a main processing chamber (7). Suitable conveying means (8) are provided to convey the particulate matter through the preheating and main processing sections and the apparatus, including the input (12) thereto and output (9) therefrom, is suitably constructed to prevent dangerous leakage of microwave energy.
Patent AU-668914-B2 (AU)
Title: Radio device
Inventor: YLIKOTILA TAAVI
IPC: H04W84/08
Filed: 1993-02-12
Granted: 1996-05-23
Abstract: PCT No. PCT/FI93/00047 Sec. 371 Date Nov. 7, 1994 Sec. 102(e) Date Nov. 7, 1994 PCT Filed Feb. 12, 1993 PCT Pub. No. WO93/16530 PCT Pub. Date Aug. 19, 1993A radio device for operation in at least two different radio systems having unequal bands of operating frequencies represented by channels numbers. The device includes a radio transmitter; a radio receiver; a frequency synthesizer for generating local oscillator frequencies for the radio transmitter and radio receiver, respectively; and a control for controlling the frequency synthesizer so as to lock it to transmitting and receiving frequencies corresponding to a selected channel number. The control includes a memory for storing frequency synthesizer control data of a single channel number for each different radio system, on the basis of which control data the control is capable of deriving control data of any other channel number for the radio system in which the radio device is currently operating.
Patent AU-707028-B2 (AU)
Title: Use,in a composition, of an extract of at least one labiate
Inventor: BRETON LIONEL
IPC: A61P17/04
Filed: 1997-07-11
Granted: 1999-07-01
Abstract: PCT No. PCT/FR97/01288 Sec. 371 Date Mar. 9, 1998 Sec. 102(e) Date Mar. 9, 1998 PCT Filed Jul. 11, 1997 PCT Pub. No. WO98/04276 PCT Pub. Date Feb. 5, 1998The subject of the present invention is an extract of at least one plant of the Labiatae family, the said plant being cultured in vitro. Its subject is also a cosmetic or pharmaceutical composition comprising, as active ingredient, at least an effective quantity of the said extract. The invention finally relates to the use of such an extract in a cosmetic composition or for the preparation of a pharmaceutical composition for controlling disorders involving an inflammatory process or an allergic process, and a process of cosmetic treatment involving such an extract.
Patent AU-752415-B2 (AU)
Title: Method for the treatment of fertility disorders
Inventor: ENGEL JURGEN
IPC: A61K35/52
Filed: 1999-03-29
Granted: 2002-09-19
Abstract: An improvement to the method of intrauterine insemination by the administration of luteinizing hormone-releasing hormone antagonists (LHRH antagonists).
Patent AU-617494-B2 (AU)
Title: Method of treatment for autoimmune diseases
Inventor: SHERMAN FRED P
IPC: A61P29/00
Filed: 1989-07-19
Granted: 1991-11-28
Abstract: A method of treating a human or animal patient suffering from an autoimmune disease comprises daily administration to such patient of from about 1 to about 100 mg of the narcotic antagonists nalmefene or naltrexone. The nalmefene (6-methylene-6-desoxy-N-cyclopropyl-methyl-14--hydroxydihydronormorphine) or naltrexone (N-cyclopropylmethyl--14-hydroxy-dihydromorphinone) may be administered in equally divided doses from one to four times daily, preferably by the oral route. Parenteral administration may be utilized where suitable.
Patent AU-567604-B2 (AU)
Title: Method and system for detecting an indicating device
Inventor: ASBRINK LEIF
IPC: G08B13/24
Filed: 1985-02-05
Granted: 1987-11-26
Abstract: A method of detecting the presence of an indicating device in a restricted investigation zone, comprising the detecting of an indicating device (31) of a highly permeable material by emitting and receiving a magnetic field, where two coils (1, 2) are caused to emit a high-frequency magnetic alternating field, and a first one of the coils (1) emits an alternating field with a frequency (f,) different from the fre- quence (f<sub>2</sub>) of the field emitted by the second one of the coils (2), and at least one difference and/or sum frequency n f<sub>1</sub> + m f. occurring by intermodulation by means of the indicating device (31), where n and m are positive or negative integers, is caused to be received by one or several coils (9). According to the invention, a third low-frequency magnetic alternating field is caused to be emitted in said zone with a frequency (f,) substantially lower than the frequencies (f<sub>1</sub>, f<sub>2</sub>), which low-frequency field is caused to have a field intensity sufficiently high, independently of the fields with the frequencies (f,) and (f<sub>2</sub>) to put the indicating device (31) into saturated condition in step with the frequency of the low-frequency field. A filed re-emitted from the indicating device (31) hereby is detected by means of a detector device as an intermodulation occurring periodically with the frequency of the low-frequency field between the frequencies (f,) and (f<sub>2</sub>).
Patent AU-721036-B2 (AU)
Title: Process for preparing imidazoquinolinamines
Inventor: GERSTER JOHN F
IPC: C07D/
Filed: 1996-10-22
Granted: 2000-06-22
Abstract: A process for preparing 1H-imidazo[4,5-c]quinolin-4-amines is disclosed. The process involves reacting a 6H-imidazo[4,5-c]tetrazolo[1,5-a]quinoline with triphenylphosphine and hydrolyzing the product thereof.
Patent AU-763120-B2 (AU)
Title: System, apparatus, and method for underwater tagging of marine fauna
Inventor: GUDBJORNSSON SIGMAR
IPC: A01K61/00
Filed: 2000-05-11
Granted: 2003-07-10
Abstract: A system, apparatus, and method for underwater self-contained and remotely controllable tagging of marine fauna involves emplacement of a tagging unit that can be used for example in a fishing trawl and establishment of communications with the unit through a cable wire that may be conventional. Numerous types of information can be recorded in relation to the tagging, including two- and/or three-dimensional images of the animal, to be used at a later date when the tagged animal is recovered. The method decreases tagging mortality and the biological effects of tagging on the animals, since they are not exposed to temperature and pressure changes, human handling and, at times, anesthesia. The embodiment makes it possible to tag deep-sea species that have never been tagged due to the fact that they would not survive the ambient changes of coming to the water's surface.
Patent AU-575416-B2 (AU)
Title: Electroviscous silicone suspension
Inventor: GOSSENS JOHN
IPC: C10M169/00
Filed: 1985-07-23
Granted: 1988-07-28
Abstract: The electroviscous suspension is based on a mixture of aqueous silica gel with silicone oil as the liquid phase to which a dispersant is added. The dispersant consists of amino functional or silicon-functional polysiloxanes having a molecular weight above 800. The concentration of the dispersant is from 1 to 30% by weight and preferably from 5 to 20% by weight, based on the silica gel particles. Electroviscous suspensions such as these are distinguished by the fact that they are highly compatible with elastomeric materials, non-sedimenting, non-inflammable and physiologically acceptable. In addition, they are heat- and freeze-resistant over a wide temperature range and are largely unaffected by temperature and pressure in their viscosity.
Patent AU-783365-B2 (AU)
Title: Coloured anhydrous gel element
Inventor: SHAH SYED ASHFAQ ALI
IPC: A61L9/01
Filed: 2001-04-19
Granted: 2005-10-20
Abstract: A colored anhydrous gel element for perfuming or deodorizing air or enclosed spaces is provided. The element is formed by cross-linking a functionalized liquid polymer selected from maleinized polybutadiene, maleinized polyisoprene or a copolymer of ethylene and maleic anhydride with a cross-linking agent which contains at least one complementary functional group in the presence of a non-aqueous perfume or deodorizing base and a least one metal-free solvent dye which is soluble in the non-aqueous perfume or deodorizing base, or which is provided as a solution in a non-aqueous solvent which is compatible with the non-aqueous perfume or deodorizing base. The gel elements may be incorporated into devices which are used as air fresheners or deodorizers.
Patent AU-713222-B2 (AU)
Title: Morphogen-induced dentine regeneration
Inventor: CHARETTE MARC F
IPC: C07K14/47
Filed: 1996-02-14
Granted: 1999-11-25
Abstract: Disclosed are methods and compositions for inducing dentine morphogenesis in a mammal. The compositions include a morphogen and are useful, e.g., in methods for sealing a cavity and desensitizing a tooth to perception of pressure and/or temperature. Preferred morphogens for use herein include osteogenic proteins, e.g., OP-1.